Xos director Dietmar Ostermann sells $12,747 in company stock

Eli Lilly (LLY +0.88%) and Novo Nordisk (NVO +1.30%) are currently the leaders in the weight loss market. Their medicines have proved highly effective and generate billions in annual sales. However, drugs such as Wegovy and Zepbound are intended to treat patients with common forms of obesity. A little-known biotech, Rhythm Pharmaceuticals (RYTM +0.99%), has…

TAIPEI, 30. Juli 2026 /PRNewswire/ — Dasher Neuroscience Holdings Inc. (TPEx: 7829) („Dasher Neuroscience”), ein KI-gestütztes biopharmazeutisches Unternehmen, das sich auf die Entdeckung und Entwicklung von Medikamenten für das Zentralnervensystem (ZNS) konzentriert, gab heute den erfolgreichen Abschluss der Patientenrekrutierung für seine weltweite, multizentrische klinische Phase-2-Studie bekannt. In dieser Studie wird YA-101 untersucht, das führende Wirkstoffkandidat…

The S&P 500 ended its choppy week in the red, ultimately finishing with a loss of 0.6%. This marks the second straight weekly decline, the longest streak since late March. Key Takeaways The S&P 500 posted a 0.6% weekly loss. The index is currently sitting 2.6% below its record close reached on June 2nd, 2026….

Bitcoin was on track for a weekly gain of around 23% Friday, following a spate of positive developments for the world’s largest cryptocurrency. Bitcoin was trading 6% higher at about $77,000, up from about $62,800 at the start of the week. Crypto-linked stocks rose, with Coinbase advancing 8% and Strategy up 6%. The rally began…

-Biosidus amplía su capacidad de fabricación de productos biológicos y refuerza su capacidad de suministro global de agalsidasa beta BUENOS AIRES, Argentina, 27 de agosto de 2026 /PRNewswire/ — Biosidus, una empresa argentina de biotecnología con más de cuatro décadas de experiencia en el desarrollo y la fabricación de medicamentos biosimilares, ha anunciado que su…